Avera Pharmaceuticals, Inc. Licenses From Cornell University a Proprietary Surgical Muscle Relaxant and Reversal Agent Compound for the Anesthesia Market

Published: Mar 21, 2007

SAN DIEGO--(BUSINESS WIRE)--Avera Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced today that it has licensed two products from Cornell University. Both compounds were developed by a research team led by Dr. John Savarese, Chairman of the Department of Anesthesiology at the Weill Cornell Medical College.

Back to news